ABSTRACT
Primary monophasic synovial sarcoma of the lung is rarely seen in clinical practice. We report the case of a 60-year-old male who underwent a left lower lobectomy for lung sarcoma. The patient received adjuvant therapy after surgery. Diagnosis was confirmed with SYT-SSX2 translocation detection.
Subject(s)
Lung Neoplasms/pathology , Sarcoma, Synovial/pathology , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Humans , Lung Neoplasms/genetics , Lung Neoplasms/therapy , Male , Middle Aged , Oncogene Proteins, Fusion/genetics , Pneumonectomy , Sarcoma, Synovial/genetics , Sarcoma, Synovial/therapy , Translocation, GeneticABSTRACT
Postsurgical chylothorax after lung resection has an important associated rate of morbidity and mortality, and a large proportion of cases require re-exploration. The most desirable and least aggressive option is conservative treatment. The use of octreotide seems to be associated with a higher rate of resolution without the need for surgical intervention. We present 4 cases in which this drug showed excellent efficacy and minimal adverse effects in the resolution of postsurgical chylothorax.
